Bio€quity Europe 2024 preview: Rising above the noise 

Looking ahead to the twenty-fourth incarnation of BioCentury’s European meeting

This year’s Bio€quity Europe conference will focus on how European biotechs can rise above the noise to attract investors, BioCentury co-founder, President and CEO David Flores said on a special edition of the BioCentury This Week podcast previewing the twenty-fourth edition of the meeting, which kicks off May 12 in San Sebastián, Spain, in Basque Country. Gaining the attention of partners and talent will also be in the spotlight.

McKinsey & Co.’s Alexandra Zemp and Paula Olazábal of Ysios Capital, which chairs Bio€quity’s regional host committee, joined Flores, Editor in Chief Simone Fishburn and head of BD Joshua Berlin to outline the opportunities and challenges faced by Spain’s biopharma ecosystem and preview some of the conference’s networking events, fireside chats and panel discussions.  

Claire Macht, portfolio director, Europe, of BioCentury’s conference partner EBD Group, also joined the podcast to detail what to expect in terms of attendees and one-on-one partnering meetings at the event. 

Bio€quity Europe 2024 is sold out, but space on the waitlist remains, and digital passes are available. See the conference website for more information.